Role of the brain in energy balance and obesity

American Journal of Physiology

Volumn 271, Issue 3 PART 2, 1996, Pages

  Levin, Baery E ^a,c   Routh, Vanessa H ^b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autonomie nervous system; Parasympathetic nervous system; Sympathetic nervous system

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; MONOAMINE; NEUROPEPTIDE Y;

ANIMAL CELL; AUTONOMIC NERVOUS SYSTEM; BODY WEIGHT; CALORIC INTAKE; ENERGY BALANCE; ENERGY EXPENDITURE; HUMAN; HUMAN CELL; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW;

ANIMALS; BRAIN; ENERGY METABOLISM; HUMANS; NEURAL PATHWAYS; OBESITY;

EID: 0029797442     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.271.3.r491     Document Type: Article

References (143)

1. Adachi, A., M. Kobashi, N. Miyoshi, and G. Tsukamoto. Chemosensitive neurons in the area postrema of the rat and their possible functions. Brain Res. Bull. 26: 137-140, 1991.
2. Adachi, A., N. Shimizu, Y. Oomura, and M. Kobashi. Convergence of heptoportal glucose-sensitive afferent signals to glucose-sensitive units within the nucleus of the solitary tract. Neurosci. Lett. 46: 215-218, 1984.
3. Ahlskog, J. E., and B. G. Hoebel, Overeating and obesity from damage to a noradrenergic system in the brain. Science Wash. DC 182: 166-169, 1973.
4. Ahmad, I., A. W. Steggeles, A. J. Carrillo, and J. A. Finkelstein. Developmental changes in levels of growth hormone mRNAin Zucker rats. J. Cell. Biochem. 43: 59-66, 1990.
5. Angel, I., and M.-A. Taranger. Coupling between hypothalamic ct2-adrenoceptors and [3H]mazindol binding sites in response to several hyperglycémie stimuli in mice. Brain Res. 490: 367-372, 1991.
6. + channels. Pfluegers Arch. 415: 479483, 1990.
7. Baranowska, B., S. P. Singh, P. Soszynski, J. Nowakowski, and W. Jeske. The role of opiate, dopaminergic, and noradrenergic systems in the hypothalamo-pituitary dysfunction in obesity. Acta Endocrinol. 116: 221-228, 1987.
8. Beck, B., A. Burlet, J.-P. Nicolas, and C. Burlet. Unexpected regulation of hypothalamic neuropeptide Y by food deprivation and refeeding in the Zucker rat. Life Sci. 50: 923-930, 1992.
9. Belanger, A. J., L. A. Cupples, and B. B. D'Agostino. Means at each examination and inter-examination consistency of specified characteristics: Framingham Heart Study, 30 year followup. In: The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Sect. 36, edited by W. B. Kännel, P. A. Wolf, and R. J. Garrison. Washington, DC: Government Printing Office, 1988. (NIH publication no. 882970)
10. Berthoud, H.-R. Cephalic phase insulin response as a predictor of body weight gain and obesity induced by a palatable cafeteria diet. J. Obesity Weight Reg. 4: 120-128, 1985.
11. Bestetti, G. E., F. Abramo, C. Guillaume-Gentil, F. RohnerJeanrenaud, B. Jeanrenaud, and G. L. Rossi. Changes in the hypothalamo-pituitary-adrenal axis of genetically obese fa I fa rats: a structural, immunocytochemical, and morphometrical study. Endocrinology 126: 1880-1887, 1990.
12. Billington, C. J., J. E. Briggs, S. Harker, M. Grace, and A. S. Levine. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1765R1770, 1994.
13. Bjorntorp, P. Neuroendocrine abnormalities in human obesity. Metabolism 44: 38-41, 1995.
14. +-channels in mouse pancreatic ß-cells. Proc. R. Soc. Land. B. Biol. Sci. 243: 139-144, 1991.
15. Bouchard, C., and L. Perusse. Genetics of obesity. Annu. Rev. Nutr. 13: 337-354, 1993.
16. Bovetto, S., and D. Richard. Lesion of central nucleus of amygdala promotes fat gain without preventing effect of exercise on energy balance. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38): R781-R786, 1995.
17. Bray, G. A., and T. F. Gallagher, Manifestation of hypothalamic obesity in man. A comprehensive investigation of eight patients and a review of the literature. Medicine 54: 301-330, 1975.
18. Campfleld, L. A., and F. J. Smith. Functional coupling between transient declines in blood glucose and feeding behavior: temporal relationships. Brain Res. Bull. 17: 427-433, 1986.
19. Campfleld, L. A., F. J. Smith, Y. Guisez, R. Devos, and P. Burn. Recombinant mouse OB protein: evidence for a periph- eral-signal-linking adiposity and central neural networks. Science Wash. DC 269: 546-549, 1995.
20. Chang, S., B. Graham, F. Yakubu, D. Lin, J. C. Peters, and J. O. Hill. Metabolic differences between obesity-prone and obesity-resistant rats. Am. J. Physiol. 259 (Regulatory Integrative Comp. Physiol. 28): R1103-R1110, 1990.
21. Chavez, M., K. Kaiyala, L. J. Madden, M. W. Schwartz, and S. C. Woods. Intraventricular insulin and the level of maintained body weight in rats. Behav. Neurosci. 109: 528-531, 1995.
22. Chronwall, B. M., D. A. Dimaggio, V. J. Massari, V. M. Pickel, D. A. Ruggerio, and T. L. O'Donohue. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15: 1159-1181, 1985.
23. Chua, S. C., Jr., W. K. Chung, X. S. Wu-Peng, Y. Zhang, S.-M. Liu, L. Tartaglia, and R. L. Leibel. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science Wash. DC 271: 994-996, 1996.
24. Considine, R. V., E. L. Considine, C. J. Williams, M. R. Nyce, S. A. Magosin, T. L. Bauer, E. L. Rosato, J. Colberg, and J. F. Caro. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J. Clin. Invest. 95: 2986-2988, 1995.
25. Corbett, S. W., J. S. Stern, and R. E. Keesey. Energy expenditure in rats with diet-induced obesity. Am. J. Clin. Nutr. 44: 173-180, 1986.
26. Cusin, I., A. Sainsbury, P. Doyle, P. Rohner-Jeanrenaud, and B. Jeanrenaud. The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 44: 1467-1470, 1995.
27. Dryden, S., L. Pickavance, H. M. Frankish, and G. Williams. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res. 690: 185-188, 1995.
28. Dunn-Meynell, A., L. I. Benowitz, and B. E. Levin. Vibrissectomy induced changes in GAP-43 immunoreactivity in the adult rat barrel cortex. J. Comp. Neural. 315: 160-170, 1992.
29. Fernstrom, M. H., and J. D. Fernstrom. Effect of chronic protein ingestion on rat central nervous system tyrosine levels and in vivo tyrosine hydroxylation rate. Brain Res. 672: 97-103, 1995.
30. Figlewicz, D. P., K. Bentson, and I. Ocrant. The effect of insulin on norepinephrine uptake by PC 12 cells. Brain Res. Bull. 32: 425-431, 1993.
31. Figlewicz, D. P., D. M. Dorsa, L. J. Stein, D. G. Baskin, T. Paquette, M. R. C. Greenwood, S. C. Woods, and D. Porte, Brain and liver insulin binding is decreased in Zucker rats carrying the "fa" gene. Endocrinology 117: 1537-1543, 1985.
32. Flatt, J. P. Influence of body composition on food intake. In: Nutrient Regulation During Pregnancy, Lactation and Growth, edited by L. Alien, J. King, and B. Lonnerdal. New York: Plenum, 1994, p. 27-44.
33. Friedman, M. I., M. G. Tordoff, and I. Ramirez. Integrated metabolic control of food intake. Brain Res. Bull. 17: 855-859, 1986.
34. Fukagawa, K., T. Sakata, H. Yoshimatsu, K. Fujimoto, and T. Shiraishi. Disruption of light-dark cycle of feeding and drinking behavior, and ambulatory activity induced by development of obesity in the Zucker rat. Int. J. Obesity 12: 481-490, 1987.
35. Fuxe, K. Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine naerve terminals in the central nervous system. Acta Physiol. Scand. 64, Suppl. 247: 37-84, 1965.
36. Gallagher, M., P. W. Graham, and P. C. Holland. The amygdala central nucleus and appetitive Pavlovian conditioning: lesions impair one class of conditioned behavior. J. Neurosci. 10: 1906-1911, 1990.
37. Goldman, C. K., L. Marino, and S. F. Leibowitz. Postsynaptic ceg-noradrenergic receptors mediate feeding induced by paraventricular nucleus injection of norepinephrine and clonidine. Eur. J. Pharmacol. 115: 11-19, 1985.
38. Grinker, J., J. Hirsch, and B. E. Levin. The affective responses of obese patients to weight reduction: a differentiation based on age at onset of obesity. Psychosom. Med. 35: 57-59, 1973.
39. Guillaume-Gentil, C., F. Rohner-Jeanrenaud, F. Abramo, G. E.Bësïètti, G. L. Rossi, and B.Jeanrenaudï Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa I fa, rat. Endocrinology 126: 1873-1879, 1990.
40. Halaas, J. L., K S. Gajiwala, M. Maffei, S. L. Cohen, D. Rabinowitz, R. L. Lallone, S. K. Burley, and J. M. Friedman. Weight-reducing effects of plasma protein encoded by the obese gene. Science-Wash. DC 269: 543-546, 1995.
41. Hamilton, B. S., D. Paglia, A. Y. M. Kwan, and M. Deitel. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med. 1: 953-956, 1995.
42. Harfstrand, A., K. Fuxe, L. F. Agnati, P. Eneroth, L. Zini, M. Zoll, K. Andersson, G. Voneuler, L. Terenius, V. Mutt, and M. Goldstein. Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function. Neurochem. Int. 8: 355-376, 1986.
43. Hetherington, A. W., and S. W. Ranson. Hypothalamic lesions and adiposity in the rat. Anat.Record 78: 149-172, 1940.
44. Ikeda, H., D. B. West, J. J. Pustek, D. P. Figlewicz, M. R. C. Greenwood, D. Porte, Jr., and S. C. Woods. Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 7: 381-386, 1986.
45. Jeanrenaud, B. Insulin, corticosterone and the autonomie nervous system in animal obesities: a viewpoint. Diabetologia 38: 998-1002, 1995.
46. Jhanwar-Uniyal, M., M. Darwish, B. E. Levin, and S. F. Leibowitz. Alterations in catecholamines levels and turnover in discrete brain areas after food deprivation. Pharmacol. Biochem. Behav. 26: 271-275, 1987.
47. Keesey, R. E., and S. W. Corbett. Metabolic defense of the body weight set-point. In: Eating and its Disorders, edited by A. J. Stunkard and E. Stellar. New York: Raven, 1984, p. 87-96.
48. Keesey, R. E., J. S. Mitchell, and J. W. Kemnitz. Body weight and body composition of male rats following hypothalamic lesions. Am. J. Physiol. 237 (Regulatory Integrative Comp. Physiol. 6): R68-R73, 1979.
49. Kennedy, G. C. The role of depot fat in the hypothalamic control of food intake in the rat. Proc. R. Soc. Land. B Biol. Sci. 611: 221-235, 1953.
50. King, B. M., J. M. Kass, K. L. Neville, H. Sam, A. C. Tatford III, and C. A. Zansler. Abnormal weight gain in rats with amygdaloid lesions. Physiol. Behav. 54: 467-470, 1993.
51. King, B. M., G. R. Phelps, and L. A. Frohman. Hypothalamic obesity in female rats in absence of vagally mediated hyperinsulinemia. Am. J. Physiol. 239 (Endocrinol. Metab. 2): E437E441, 1980.
52. Kow, L.-M., and D. W. Pfaff. Responses of ventromedial hypothalamic neurons to norepinephrine: dependence on dose and receptor type. Brain Res. 37: 153-158, 1987.
53. Krettek, J. E., and J. L. Price. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J. Comp. Neural. 178: 225-254, 1978.
54. Larson, D. E., R. T. Ferraro, D. S. Robertson, and E. Ravussin. Energy metabolism in weight-stable postobese individuals. Am. J. Clin. Nutr. 62: 735-739, 1995.
55. Lee, G.-H., R. Proenca, J. M. Montez, K. M. Carroll, J. G. Darvishzadeh, J. I. Lee, and J. M. Friedman. Abnormal splicing of the leptin receptor in diabetic mice. Nature Land. 379: 632-635, 1996.
56. Lee, H. C., D. L. Curry, and J. S. Stern. Direct effect of CNS - -; -_- 7orririsultnjhypCTs: ecretiQn: in: ;Qbese"Zuckerrats: involvement of : vagus nerve. Am. J. Physiol. 256 (Endocrinol. Metab. 19): E439-E444, 1989.
57. Leibowitz, S. F. Brain monoamines and peptides: role in the control of eating behavior. Federation Proc. 45: 1376-1403, 1986.
58. Leibowitz, S. F., N. J. Hammer, and K. Chang. Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat. Physiol. Behav. 27: 1031-1040, 1981.
59. Lenard, L., P. Sandor, A. Hajnal, G. Jando, Z. Karadi, and Y. Kai. Sex-dependent body weight changes after iontophoretic application of kainic acid into the LH or VMH. Brain Res. Bull. 26: 141-148, 1991.
60. Levin, B. E. Obesity-prone and -resistant rats differ in their brain 3H paraminoelonidine binding. Brain Res. 512: 54-59, 1990.
61. Levin, B. E. Increased brain 3H paraminoclonidine (ct2adrenoceptor) binding associated with perpetuation of dietinduced obesity in rats. Int. J. Obes. 14: 689-700, 1990.
62. Levin, B. E. Glucose increases rat plasma norepinephrine levels by direct action on the brain. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R1351-R1357, 1991.
63. Levin, B. E. Spontaneous motor activity during the development and maintenance of diet-induced obesity in the rat. Physiol. Behav. 50: 573-581, 1991.
64. Levin, B. E. Defective cerebral glucose utilization in dietinduced obese rats. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R787-R792, 1991.
65. Levin, B. E. Intracarotid glucose-induced norepinephrine response and the development of diet-induced obesity. Int. J. Obesity 16: 451-457, 1992.
66. Levin, B. E. Sympathetic activity, age, sucrose preference and diet-induced obesity. Obes. Res. 1: 281-287, 1993.
67. Levin, B. E. Diet cycling and age alter weight gain and insulin levels in rats. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R527-R535, 1994.
68. Levin, B. E. Reduced norepinephrine turnover in organs and brains of obesity-prone rats. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R389-R394, 1995.
69. Levin, B. E. Reduced paraventricular nucleus norepinephrine responsiveness in obesity-prone rats. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R456-R461, 1996.
70. Levin, B. E., K. L. Brown, and G. Vincent. Increased potency and binding of mazindol to putative brain anorectic receptors in obesity-prone rats. Brain Res. 668: 171-179, 1994.
71. Levin, B. E., K. Comai, R. A. O'Brian, and A. C. Sullivan. Abnormal brown adipose composition and ß-adrenoreceptor binding in obese Zucker rats. Am. J. Physiol. 243 (Endocrinol. Metab. 6): E217-E224, 1982.
72. Levin, B. E., K. Comai, and A. C. Sullivan. Metabolic and sympatho-adrenal abnormalities in the obese Zucker rat: effect of chronic phenoxybenzamine treatment. Pharmacol. Biochem. Behav. 14: 517-525, 1981.
73. Levin, B. E., and A. Dunn-Meynell. Adult rat barrel cortex plasticity occurs at 1 week but not 1 day after vibrissectomy as demonstrated by the 2-deoxyglucose method. Exp. Neural. 113: 237-248, 1991.
74. Levin, B. E., and A. Dunn-Meynell. Intracarotid glucose selectively activates PVN, VMN and arcuate neurons: a clue to glucose-induced sympathetic activation (Abstract). Obes. Res. 3: 357s, 1995.
75. Levin, B. E., M. Finnegan, J. Triscari, and A. C. Sullivan. Brown adipose and metabolic features of chronic diet-induced obesity. Am. J. Physiol. 248 (Regulatory Integrative Comp. Physiol. 17): R717-R723, 1985.
76. Levin, B. E., M. B. Finnegan, E. Marquet, and A. C. Sullivan. Defective brown adipose oxygen consumption in obese Zucker rats. Am. J. Physiol. 247 (Endocrinol. Metab. 10): E94-E100, 1984.
77. Levin, B. E., and M, W. Hamm, Plasticity of brain a-adrenoceptors during the development of diet-induced obesity in the rat. Obes. Res. 2: 230-238, 1994.
78. Levin, B. E., S. Hogan, and A. C. Sullivan. Initiation and perpetuation of obesity and obesity resistance in rats. Am. J. Physiol. 256 (Regulatory Integrative Comp. Physiol. 25): R766_ R771, 1989.
79. Levin, B. E., and B. Planas. Defective glucoregulation of brain ct2-adrenoceptors in obesity-prone rats. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R305-R311, 1993.
80. Levin, B. E., B. Planas, V. H. Routh, J. Hamilton, J. S. Stern, and B. A. Horwitz. Altered i-adrenoceptor binding in intact and adrenalectomized obese Zucker rats (fa/fa). Brain Res. 614: 146-154, 1993.
81. Levin, B. E., S. Stoddard-Apter, and A. C. Sullivan. Central activation and peripheral function of sympatho-adrenal and cardiovascular systems in the Zucker rat. Physiol. Behav. 32: 295-299, 1984.
82. Levin, B. E., and A. C. Sullivan. Catecholamine levels in discrete brain nuclei of seven month old genetically obese rats. Pharmaeol. Biochem. Behav. 1-1: 77-82, 1979.
83. Levin, B. E., and A. C. Sullivan. Dietary obesity and neonatal sympathectomy. II. Thermorégulation and brown adipose metabolism. Am. J. Physiol. 247 (Regulatory Integrative Comp. Physiol. 16): R988-R994, 1984.
84. Levin, B. E., and A. C. Sullivan. Glucose-induced norepinephrine levels and obesity resistance. Am. J. Physiol. 253 (Regulatory Integrative Comp. Physiol. 22): R475-R481, 1987.
85. Levin, B. E., and A. C. Sullivan. Glucose, insulin and sympathoadrenal activation. J. Auton. Nerv. Syst. 20: 233-242, 1987.
86. Levin, B. E., and A. C. Sullivan. Differences in saccharininduced cerebral glucose utilization between obesity-prone and resistant rats. Brain Res. 488: 221-232, 1989.
87. Levin, B. E., and A. C. Sullivan. Glucose-induced sympathetic activation in obesity-prone and resistant rats. Int. J. Obesity 13: 235-246, 1989.
88. Levin, B. E., J. Triscari, E. Marquet, and A. C. Sullivan. Dietary obesity and neonatal sympathectomy I. Effects on body composition and brown adipose. Am. J. Physiol. 247 (Regulatory Integrative Camp. Physiol. 16): R979-R987, 1984.
89. Levin, B. E., J. Triscari, and A. C. Sullivan. Abnormal sympatho-adrenal function and plasma catecholamines in obese Zucker rats. Pharmacol. Biochem. Behav. 13: 107-113, 1980.
90. Levin, B. E., J. Triscari, and A. C. Sullivan. Sympathetic activity in thyroid-treated Zucker rats. Am. J. Physiol. 243 (Regulatory Integrative Comp. Physiol. 12): R170-R178, 1982.
91. Levin, B. E., J. Triscari, and A. C. Sullivan. Altered sympathetic activity during development of diet-induced obesity in rat. Am. J. Physiol. 244 (Regulatory Integrative Comp. Physiol. 13): R347-R355, 1983.
92. Levin, B. E., J. Triscari, and A. C. Sullivan. Studies of origins of abnormal sympathetic function in obese Zucker rats. Am. J. Physiol. 245 (Endocrinol. Metab. 8): E87-E93, 1983.
93. Levin, B. E., J. Triscari, and A. C. Sullivan. Relationship between sympathetic activity and diet-induced obesity in two rat strains. Am. J. Physiol. 245 (Regulatory Integrative Comp. Physiol 14): R367-R371, 1983.
94. Levin, B. E., J. Triscari, and A. C. Sullivan. Metabolic features of diet-induced obesity without hyperphagia in young rats. Am. J. Physiol. 251 (Regulatory Integrative Comp. Physiol. 20): R433-R440, 1986.
95. Levin, B. E., J. Triscari, and A. C. Sullivan. The effect of diet and chronic obesity on brain catecholamine turnover in the rat. Pharmacol. Biochem. Behav. 24: 299-304, 1986.
96. Levine, A. S., and J. E. Morley. Neuropeptide Y: a potent inducer of consumatory behavior in rats. Peptides 5: 10251029, 1984.
97. Li, S., and G. Pelletier. The role of dopamine in the control of neuropeptide Y neurons in the rat arcuate nucleus. Neurosci. Lett. 69: 74-77, 1986.
98. Lichtenstein, S. S., C. Marinescu, and S. F. Leibowitz. Chronic infusion of norepinephrine and clonidine into the hypothalamic paraventricular nucleus. Brain Res. Bull. 13: 357-363, 1984.
99. Luiten, P. G. M., G. J. Ter Horst, and A. B. Steffens. The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Prog. Neurobiol. 28: 1-54, 1987.
100. Marfaing-Jallat, P., C. Levacher, Y. Calando, L. Picon, and L. Pejfticaud. Glucose utilization and insulin binding in diserete-brain areaefeiesi-rsswl Betea 52: 713-716, 1992.
101. Marks, J. L., M. Li, M. W. Schwartz, D. Porte, Jr., and D. G. Baskin. The effect of fasting on neuropeptide Y mRNA and insulin receptors in the rat brain. Mol. Cell. Neurosci. 3: 199-205, 1992.
102. Mayer, J. Regulation of energy intake and the body weight: the glucostatic theory and lipostatic hypothesis. Ann. NYAcad. Sci. 63: 15-43, 1955.
103. McKibbin, P. E., S. J. Cotton, S. McMillan, B. Holloway, R. Mayers, H. D. McCarthy, and G. Williams. Altered neuropeptide Y concentrations in specific hypothalamic regions of obese (fa/fa) Zucker rats. Diabetes 40: 1423-1429, 1991.
104. Meister, B., S. Ceccatelli, T. Hokfelt, N.-E. Anden, M. Anden, and E. Theodorsson. Neurotransmitters, neuropep tides and-binding- sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lésions. Exp. Brain Res. 76: 343-368, 1989.
105. Minami, S., J. Kamegai, H. Sugihara, N. Suzuki, H. Higuchi, and I. Wakabayashi. Central glucoprivation evoked by administration of 2-deoxy-D-gIucose induces expression of the c-fos gene in a subpopulation of neuropeptide Y neurons in the rat hypothalamus. Mol. Brain Res. 33: 305-310, 1995.
106. Nagashima, K., J. B. Zabriskie, and M. J. Lyons, Virusinduced obesity in mice: association with a hypothalamic lesion. J. Neuropath. Exp. Neural 51: 101-109, 1992.
107. Oomura, Y. Glucose as a regulator of neuronal activity. In: Advances in Metabolic Disorders, edited by A. J. Szabo. New York: Academic, 1983, p. 31-65.
108. Oomura, Y., H. Ooyama, M. Sugimori, T. Nakamura, andY. Yamada. Glucose inhibition of the glucose-sensitive neurone in the rat lateral hypothalamus. Nature Lond. 247: 284-286, 1974.
109. Pelleymounter, M. A., M. J. Cullen, M. B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. Effects of the obese gene product on body weight regulation in ob/ob mice. Science Wash. DC 269: 540-543, 1995.
110. Pesonen, U., R. Huupptmen, J. Rouru, and M. Koulu. Hypothalamic neuropeptide expression after food restriction in Zucker rats: evidence of persistent neuropeptide Y gene activation. Mol. Brain Res. 16: 255-260, 1992.
111. Powley, T. L., and W. L. Laughton. Neural pathways involved in the hypothalamic integration of autonomie responses. Diabetologia 20: 378-387, 1981.
112. Rawson, N. E., H. Blum, M. D. Osbakken, and M. I. Friedman. Hepatic phosphate trapping, decreased ATP, and increased feeding after 2, 5-anhydro-D-mannitol. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R112-R117, 1994.
113. Rojdmark, S., and S. Rossner. Decreased dopaminergic control of prolactin secretion in male obesity: normalization by fasting. Metabolism 40: 191-195, 1991.
114. Routh, V. H., B. A. Horwitz, D. W. Gietzen, and J. S. Stern. Hypothalamic monoaminergic activity in 11-week-old coldexposed female lean (Fa/Fa) and obese (fa/fa) Zucker rats. Obes. Res. 2: 28-37, 1994.
115. Routh, V. H., D. M. Murakami, J. S. Stern, C. A. Fuller, and B, A. Horwitz. Neuronal activity in hypothalamic nuclei of obese and lean Zucker rats. Int. J. Obes. 14: 879-891, 1990.
116. Routh, V. H., J. S. Stern, and B. A. Horwitz. Serotonergic activity is depressed in the ventromedial hypothalamic nucleus of 12-day-old obese Zucker rats. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R712-R719, 1994.
117. Routh, V. H., J. S. Stern, and B. A. Horwitz. Adrenalectomy increases serotonin turnover in brains of obese Zucker rats. Physiol. Behav. 58: 491-499, 1995.
118. Saiduddin, S., G. A. Bray, D. A. York, and R. S. Swerdloff. Reproductive function in the genetically obese "fatty" rat. Endocrinology 93: 1251-1256, 1973.
119. Sanacora, G., J. A. Finkelstein, and J. D. White. Developmental aspect of differences in hypothalamic preproneuropeptide Y messenger ribonucleic acid content in lean and genetically obese Zucker rats. J. Neuroendocrinol. 4: 353-357, 1992.
120. Scallet, A. C., and J. W. Olney. Components of hypothalamic obesity: biperidyl-mustard lesions add hyperphagia to monoso-dium glutamate-induced hyperinsulinemia. Brain Res. 374: 380-384, 1986.
121. Schenmmel A. Mickelseja, and J. L. Gill. Dietary obesity in ratsTbodywëîghf arrd body fat accretion in-sevënîraînsuotrrrn: rats. J. Nutr. 100: 1041-1048, 1970.
122. Schwartz, M. W., J. L. Marks, A. J. Sipols, D. G. Baskin, S. C. Woods, S. E. Kahn, and D. Porte, Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 128: 2645-2647, 1991.
123. Schwartz, M. W., A. Sipols, S. E. Kahn, D. F. Lattemann, G. J. Taborsky, Jr., R. N. Bergman, S. C. Woods, and D. Porte, Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E378-E383, 1990.
124. Sclafani, A., and D. Springer. Dietary obesity in adult rats: similarities to hypothalamic and human obesity syndromes. Physiol: Behav. 17: 461-471, 1976.
125. Shimazu, T., M. Noma, and M. Saito. Chronic infusion of norepinephrine into the ventromedial hypothalamus induces obesity in rats. Brain Res. 369: 215-223, 1986.
126. Sokoloff, L., M, Reivich, C. Kennedy, M. H. Desrosiers, C. S. Patlak, O. Pettigrew, O. Sakaruda, and M. Shinohara. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 23: 897-916, 1977.
127. Stanley, B. G., S. E. Kyrkouli, S. Lampert, and S. F. Léibowitz. Neuropepetide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1: 1189-1192, 1986.
128. Steffens, A. B., G. Damsma, J. van der Gugten, and P. G. M. Luiten. Circulating free fatty acids, insulin, and glucose during chemical stimulation of hypothalamus in rats. Am. J. Physiol. 247 (Endocrinol. Metab. 10): E765-E771, 1984.
129. Stephens, T. W., M. Basinski, P. K. Bristow, J. M. BueValleskey, S. G. Burgett, L. Craft, J. Hale, J. Hoffmann, H. M. Hsiung, A. Kriauclunas, W. Mackellar, Jr., P. R. Rosteck, B. Schoner, D. Smith, F. C. Tïnsley, X.-Y. Zhang, and M. Heiman. The role of neuropeptide Y in antiobesity action of the obese gene product. Nature Land. 377: 530-532, 1995.
130. Stoddard-Apter, S. L., V. K. Bergdall, D. W. Townsend, and B. E. Levin. Plasma catecholamines associated with hypothalamically-elicited defense behavior. Physiol. Behav. 36: 867-873, 1986.
131. Tartaglia, L. A., M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G. J. Richards, L. A. Campfield, F. T. Clark, J. Deeds, C. Muir, S. Sanker, A. Moriarity, K. J. Moore, J. S. Smutko, G. G. Mays, E. A. Woolf, C. A. Monroe, and R. I. Tepper. Identification and expression cloning of a leptin receptor, Ob-R. Cell 83: 1263-1271, 1995.
132. Tokunaga, K., M. Fukushima, J. W. Kemnitz, and G. A. Bray. Comparison of ventromedial and paraventricular lesions in rats that become obese. Am. J. Physiol. 251 (Regulatory Integrative Comp. Physiol. 20): R1221-R1227, 1986.
133. Trayhurn, P., J. S. Duncan, and D. V. Rayner. Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem. J. 311: 729-733, 1995.
134. Trayhurn, P., M. E. A. Thomas, J. S. Duncan, and D. V. Rayner. Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (ob/ob) mice. FEBS Lett. 368: 488-490, 1995.
135. Vander Tuig, J. G., A. W. Knehans, and D. R. Romsos. Reduced sympathetic nervous system activity in rats with ventromedialhypothalamic lesions. Life Sci. 30: 913-920, 1982.
136. Walgren, M. C., and T. L. Powley. Effects of intragastric hyperalimentation on pair-fed rats with ventromedial hypothalamic lesions. Am. J. Physiol. 248 (Regulatory Integrative Comp. Physiol. 17): R172-R180, 1985.
137. Weinsier, R. L., K. M. Nelson, K. M. Hensrud, B. E. Darnell, G. R. Hunter, and Y. Schutz. Metabolic predictors of obesity: contribution of resting energy expenditure, thermic effect of food, and fuel utilization to four-year weight gain of post-obese and never-obese women. J. Clin. Invest. 95: 980-985, 1995.
138. Wetmore, L., and D. M. Nance. Differential and sex-specific effects of kainic acid and domoic acid lesions in the lateral septal area of rats on immune function and body weight regulation. Exp. Neural 113: 226-236, 1991.
139. Wilmot, C. A., A. C. Sullivan, and B. E. Levin. Effects of diet and obesity on brain i- and 2-noradrenergic receptors in the rat.BrainRes. 453: 157-166, 1988.
140. Yoshimatsu, H., A. Niijima, Y. Oomura, K. Yamabe, and T. Katafuchi. Effects of hypothalamic lesion on pancreatic autonomie nerve activity in the rat. Brain Res. 303: 147-152, 1984.
141. Young, J. B., and I. A. McDonald. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int. J. Obes. 16: 959-967, 1992.
142. Zarjevski, N., I. Cusin, R. Vettor, F. Rohner-Jeanrenaud, B. Jeanrenaud. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes. Endocrinology 133: 1753-1758, 1993.
143. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman. Positional cloning of the mouse obese gene and its human homologue. Nature Land. 372: 425-432, 1994.